SDG target 3.3: by 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, waterborne diseases and other communicable diseases.
Working Document - Updated -February 2009
Clinical Infectious Diseases
1586 - 1594 • CID 2016:62 (15 June) • HIV/AIDS
At present at least 2.2 billion people around the world have a vision impairment, of whom at least 1 billion have a vision impairment that could have been prevented or is yet to be addressed. The world faces considerable challenges in terms of eye care, including inequalities in the coverage and qua...lity of prevention, treatment and rehabilitation services; a shortage of trained eye care service providers; and poor integration of eye care services into health systems, among others. The World report on vision aims to address these challenges and galvanize action.
more
MSF provides treatment for HIV and tuberculosis (TB) in more than 20 countries around the world. The report Burden sharing or burden shifting? How the HIV/TB response is being derailed examines the situation in nine countries where MSF runs programmes: Central African Republic, Democratic Republic ...of Congo, Eswatini, Guinea, Kenya, Malawi, Mozambique, Myanmar and Zimbabwe. With a focus on the financial resources available, this report highlights the current risks and gaps in HIV and TB service delivery in these countries.
Given the findings of gaps in diagnosis, prevention and care services and dwindling resources, MSF calls for a robust assessment of the needs and the resource capacity of each affected country, and calls on international donors to ensure that the financial burden is shared, rather than shifted onto those countries worst affected by the diseases.
more
States have a moral and legal obligation—under the Universal Declaration of Human Rights, human rights treaties, the 2030 Agenda for Sustainable Development and other international obligations—to remove discriminatory laws and to enact laws that protect people from discrimination
Cet outil peut être utilisé pour améliorer la qualité du programme ASC. Pour identifier et combler les lacunes dans la conception et la mise en œuvre du programme ASC, veuillez compléter les informations ci-dessous
Global HIV Strategic Information Working Group
Usage Guidelines
Junior and Senior Secondary
Extra Curricular Life Skills Training Manual For Adolescents 13 to 18 Years of Age
“Protecting Our Peers From HIV Infection”
The Youth Health and Development Programme Government of the Republic of Namibia and UNICEF Programme of Cooperation 1997-2001
November 1999
This manual was designed to support the GRN-UNICEF Youth Health and Development Programme with the aim of sustaining My Future is My Choice graduates and other young people’s peer education activities. It was written and reviewed in a three-day workshop in November 1999 and in the following weeks ...with assistance from participating organizations including AIDS Care Trust, Catholic AIDS Action, Ella Du Plessis High School AIDS Awareness Club, the Namibian Broadcasting Corporation, NACAMA, the National Youth Council of Namibia, PEDI/PECP, Polytechnic of Namibia, the University of Namibia and UNICEF. It was revised by Jennifer Lentfer of the Youth Health and Development Program of UNICEF Namibia in July of 2001.
more
Rueda S, et al. BMJ Open 2016;6:e011453. doi:10.1136/bmjopen-2016-011453
Relevance and effectiveness of World Bank support for public sector capacity building in Sub-Saharan Africa from 1995 to 2004. Benin is part of a six country case study.
Цель настоящего документа («Основные положения») заключается в подготовке рекомендаций относительно необходимых на национальном уровне мер по адаптации стратег...и Всемирной организации здравоохране-ния по ликвидации туберкулеза, началу ее осуществления и реализации.
more
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group